Mirum Pharmaceuticals (NasdaqGM:MIRM) FY Conference January 14, 2026 02:15 PM ET Company ParticipantsChris Peetz - CEOConference Call ParticipantsJess Fye - Managing Director and Equity Research AnalystNone - AnalystJess FyeGreat. Good morning, everyone. My name's Jess Fye. I'm a biotech analyst at J.P. Morgan, and we're continuing our 44th annual healthcare conference this morning with Mirum. First, you're going to hear a presentation from the company, and then we're going to go into a Q&A session. So for ...